Regent Pacific Group Limited (FRA:RPG)

Market Cap	20.04M +76.0%
Revenue (ttm)	309.17K -49.5%
Net Income	-4.01M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0630
Previous Close	0.0650
Day's Range	0.0630 - 0.0630
52-Week Range	0.0485 - 0.1270
Beta	n/a
RSI	14.23
Earnings Date	Mar 26, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholog...

• Industry: Investors, not elsewhere classified
• Founded: 1991
• Employees: 16
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RPG

Financial Performance

In 2025, Regent Pacific Group's revenue was $363,000, a decrease of -49.51% compared to the previous year's $719,000. Losses were -$4.71 million, 5.09% more than in 2024.

Financial numbers in USD